Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Feb:1188:96-102.
doi: 10.1111/j.1749-6632.2009.05088.x.

Extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy

Affiliations
Review

Extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy

Izhak Kehat et al. Ann N Y Acad Sci. 2010 Feb.

Abstract

Cardiac hypertrophy results from increased mechanical load on the heart and through the action of neurohumoral mediators. ERK1/2 are known to be activated in response to almost every stress- and agonist-induced hypertrophic stimulus examined to date, suggesting the straightforward hypothesis that these kinases are required for promoting the cardiac growth response. However, recent data from genetically modified mouse models suggest a more complicated picture. For example, inducible expression of dual-specificity phosphatase 6, an ERK1/2-inactivating phosphatase, eliminated ERK1/2 phosphorylation in transgenic mice, but it did not diminish the hypertrophic response to pressure overload. Similarly, Erk1-/- and Erk2+/- mice showed no reduction in stimulus-induced cardiac growth in vivo. However, blockade or deletion of cardiac ERK1/2 did predispose the heart to decompensation and failure after long-term pressure overload. Thus, ERK1/2 signaling is not to be absolutely necessary for mediating cardiac hypertrophy, although it does appear to provide critical protective effects/signals during stress-stimulation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The MAPK signaling cascades are composed of three to five levels of kinases that constitute a phosphorylation-based amplification network. They are generally sub-classified into three main branches, consisting of p38 kinases, c-Jun N-terminal kinases (JNKs), and ERK1/2. However, additional kinases in this cascade include ERK5, which is activated by MEK5.
Figure 2
Figure 2
Working model for ERK activation. Baseline levels of phospho-ERK oscillate at baseline. A stimulus activating the ERK pathway increase the level of activated ERK. In contrast, mice with overexpression of activated MEK1 have sustained increased activation, and mice with overexpression of DUSP6 have very low baseline and post-stimulus levels. Mice with deletion of DUSP6 appear to have increased baseline activation, but unchanged post stimulus levels.

Similar articles

Cited by

References

    1. HO KK, PINSKY JL, KANNEL WB, LEVY D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol. 1993;22:6A–13A. - PubMed
    1. KLEIN L, et al. Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations. Am J Cardiol. 2003;91:18F–40F. - PubMed
    1. BUENO OF, MOLKENTIN JD. Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ Res. 2002;91:776–81. - PubMed
    1. GARRINGTON TP, JOHNSON GL. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol. 1999;11:211–8. - PubMed
    1. WELLBROCK C, KARASARIDES M, MARAIS R. The RAF proteins take centre stage. Nat Rev Mol Cell Biol. 2004;5:875–85. - PubMed

Publication types

MeSH terms

Substances